Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from March 1, 2020, to March 31, 2020. The report details consolidated transactions of securities and derivatives involving the company's Group and Related Persons, specifically the Board of Directors and Management, in compliance with Article 11 of CVM Instruction # 358/2002. The filing was signed on April 8, 2020.
Key Financial Metrics
This filing does not contain consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the company. It exclusively reports on insider trading activity.
| Category | Transaction Type | Quantity | Volume (R$) |
|---|---|---|---|
| Group and Related Persons | Total Buy (Shares) | 137,631 | 433,749.60 |
| Total Sell (Shares) | 34,562 | 433,753.10 | |
| Board of Directors | Total Buy (Shares) | 196,565 | 327,598.08 |
| Total Sell (Shares) | 55,270 | 854,899.20 | |
| Management | Transactions | None | N/A |
Material Changes
The filing does not provide comparative data against prior periods to determine material changes in trading volume or value. It serves as a standalone disclosure of activity for March 2020.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or contingencies. It is a regulatory disclosure of specific securities transactions, including option exercises and direct sales via intermediaries (e.g., XP Corretora).
Investor Verification Checklist
- Verify the final share balances for the Board of Directors (5,151,871 Common Shares) and the Group (34,130,286 Common Shares) as of March 31, 2020.
- Confirm that Management reported no transactions during this period.
- Note that a significant portion of "Buy" transactions were option exercises with a price of R$ 0.00 (subscription) or low strike prices, rather than open market purchases.
- Review the specific sale prices (ranging from R$ 1.77 to R$ 15.48) to understand the valuation context for insider disposals in March 2020.